A detailed history of Morgan Stanley transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,206,714 shares of KURA stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,206,714
Previous 1,328,514 9.17%
Holding current value
$10.8 Million
Previous $27.4 Million 13.8%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.57 - $23.23 $2.26 Million - $2.83 Million
-121,800 Reduced 9.17%
1,206,714 $23.6 Million
Q2 2024

Oct 17, 2024

SELL
$17.53 - $22.98 $507,440 - $665,202
-28,947 Reduced 2.13%
1,328,514 $27.4 Million
Q2 2024

Aug 14, 2024

SELL
$17.53 - $22.98 $507,440 - $665,202
-28,947 Reduced 2.13%
1,328,514 $27.4 Million
Q1 2024

Oct 17, 2024

BUY
$13.42 - $23.53 $388,468 - $681,122
28,947 Added 2.18%
1,357,461 $29 Million
Q1 2024

Aug 16, 2024

BUY
$13.42 - $23.53 $355,710 - $623,686
26,506 Added 1.99%
1,357,461 $29 Million
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $355,710 - $623,686
26,506 Added 1.99%
1,357,461 $29 Million
Q4 2023

Aug 16, 2024

BUY
$7.58 - $14.38 $18,502 - $35,101
2,441 Added 0.18%
1,330,955 $19.1 Million
Q4 2023

Feb 13, 2024

BUY
$7.58 - $14.38 $8.87 Million - $16.8 Million
1,169,992 Added 726.87%
1,330,955 $19.1 Million
Q3 2023

Nov 15, 2023

SELL
$8.44 - $11.86 $1.07 Million - $1.5 Million
-126,764 Reduced 44.06%
160,963 $1.47 Million
Q2 2023

Aug 14, 2023

BUY
$9.62 - $13.99 $737,671 - $1.07 Million
76,681 Added 36.33%
287,727 $3.04 Million
Q1 2023

May 15, 2023

SELL
$10.71 - $14.6 $693,429 - $945,291
-64,746 Reduced 23.48%
211,046 $2.58 Million
Q4 2022

Feb 14, 2023

SELL
$11.23 - $16.9 $1.29 Million - $1.94 Million
-114,716 Reduced 29.38%
275,792 $3.42 Million
Q3 2022

Nov 14, 2022

SELL
$12.01 - $19.45 $3.67 Million - $5.94 Million
-305,292 Reduced 43.88%
390,508 $5.33 Million
Q2 2022

Oct 27, 2022

BUY
$10.71 - $18.33 $2.69 Million - $4.6 Million
250,960 Added 56.42%
695,800 $12.8 Million
Q2 2022

Aug 15, 2022

BUY
$10.71 - $18.33 $2.69 Million - $4.6 Million
250,960 Added 56.42%
695,800 $12.8 Million
Q1 2022

Oct 27, 2022

SELL
$11.78 - $16.98 $2.96 Million - $4.26 Million
-250,960 Reduced 36.07%
444,840 $7.15 Million
Q1 2022

May 13, 2022

BUY
$11.78 - $16.98 $4.26 Million - $6.14 Million
361,551 Added 434.09%
444,840 $7.15 Million
Q4 2021

Feb 14, 2022

SELL
$12.22 - $19.57 $949,958 - $1.52 Million
-77,738 Reduced 48.28%
83,289 $1.17 Million
Q3 2021

Nov 15, 2021

BUY
$15.42 - $21.72 $2.48 Million - $3.5 Million
161,027 New
161,027 $3.02 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.